Log in

NASDAQ:XNPT - XenoPort Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$7.07
+7.07 (+∞)
(As of 07/6/2016)
Add
Today's Range
$7.07
Now: $7.07
$7.07
50-Day Range N/A
52-Week Range
$3.35
Now: $7.07
$7.86
VolumeN/A
Average Volume1.22 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
XenoPort, Inc is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
Current SymbolNASDAQ:XNPT
CUSIP98411C10
Phone+1-408-6167200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive XNPT News and Ratings via Email

Sign-up to receive the latest news and ratings for XNPT and its competitors with MarketBeat's FREE daily newsletter.


XenoPort (NASDAQ:XNPT) Frequently Asked Questions

What is XenoPort's stock symbol?

XenoPort trades on the NASDAQ under the ticker symbol "XNPT."

Has XenoPort been receiving favorable news coverage?

Media headlines about XNPT stock have been trending extremely negative on Monday, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. XenoPort earned a news impact score of -4.5 on InfoTrie's scale. They also assigned news stories about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for XenoPort.

Who are some of XenoPort's key competitors?

What other stocks do shareholders of XenoPort own?

Based on aggregate information from My MarketBeat watchlists, some companies that other XenoPort investors own include Netflix (NFLX), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), Ionis Pharmaceuticals (IONS), Supernus Pharmaceuticals (SUPN), XOMA (XOMA), Booking (BKNG), Celgene (CELG), Endocyte (ECYT) and Endo International (ENDP).

What is XenoPort's stock price today?

One share of XNPT stock can currently be purchased for approximately $7.07.

What is XenoPort's official website?

The official website for XenoPort is http://www.xenoport.com/.

How can I contact XenoPort?

XenoPort's mailing address is 2000 Seaport Blvd Ste 300, REDWOOD CITY, CA 94063-5584, United States. The biopharmaceutical company can be reached via phone at +1-408-6167200.


MarketBeat Community Rating for XenoPort (NASDAQ XNPT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  137 (Vote Outperform)
Underperform Votes:  162 (Vote Underperform)
Total Votes:  299
MarketBeat's community ratings are surveys of what our community members think about XenoPort and other stocks. Vote "Outperform" if you believe XNPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XNPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel